Quaranta V - Search Results

1

ACDC: Automated Cell Detection and Counting for Time-Lapse Fluorescence Microscopy.

Rundo L, Tangherloni A, Tyson DR, Betta R, Militello C, Spolaor S, Nobile MS, Besozzi D, Lubbock ALR, Quaranta V, Mauri G, Lopez CF, Cazzaniga P. Rundo L, et al. Among authors: quaranta v. Appl Sci (Basel). 2020 Sep 2;10(18):6187. doi: 10.3390/app10186187. Epub 2020 Sep 6. Appl Sci (Basel). 2020. PMID: 34306736 Free PMC article.

2

What lies beneath: looking beyond tumor genetics shows the complexity of signaling networks underlying drug sensitivity.

Quaranta V, Tyson DR. Quaranta V, et al. Sci Signal. 2013 Sep 24;6(294):pe32. doi: 10.1126/scisignal.2004715. Sci Signal. 2013. PMID: 24065144 Review.

3

Beyond genetics in personalized cancer treatment: assessing dynamics and heterogeneity of tumor responses.

Tyson DR, Quaranta V. Tyson DR, et al. Among authors: quaranta v. Per Med. 2013 May 1;10(3):221-225. doi: 10.2217/pme.13.6. Per Med. 2013. PMID: 24696699 Free PMC article. No abstract available.

4

Thunor: visualization and analysis of high-throughput dose-response datasets.

Lubbock ALR, Harris LA, Quaranta V, Tyson DR, Lopez CF. Lubbock ALR, et al. Among authors: quaranta v. Nucleic Acids Res. 2021 Jul 2;49(W1):W633-W640. doi: 10.1093/nar/gkab424. Nucleic Acids Res. 2021. PMID: 34038546 Free PMC article.

5

Real-time luminescence enables continuous drug-response analysis in adherent and suspension cell lines.

Wandishin CM, Robbins CJ, Tyson DR, Harris LA, Quaranta V. Wandishin CM, et al. Among authors: quaranta v. Cancer Biol Ther. 2022 Dec 31;23(1):358-368. doi: 10.1080/15384047.2022.2065182. Cancer Biol Ther. 2022. PMID: 35443861 Free PMC article.

6

Trait variability of cancer cells quantified by high-content automated microscopy of single cells.

Quaranta V, Tyson DR, Garbett SP, Weidow B, Harris MP, Georgescu W. Quaranta V, et al. Methods Enzymol. 2009;467:23-57. doi: 10.1016/S0076-6879(09)67002-6. Methods Enzymol. 2009. PMID: 19897088 Free PMC article.

7

Quantifying heterogeneity and dynamics of clonal fitness in response to perturbation.

Frick PL, Paudel BB, Tyson DR, Quaranta V. Frick PL, et al. Among authors: quaranta v. J Cell Physiol. 2015 Jul;230(7):1403-12. doi: 10.1002/jcp.24888. J Cell Physiol. 2015. PMID: 25600161 Free PMC article.

8

MuSyC is a consensus framework that unifies multi-drug synergy metrics for combinatorial drug discovery.

Wooten DJ, Meyer CT, Lubbock ALR, Quaranta V, Lopez CF. Wooten DJ, et al. Among authors: quaranta v. Nat Commun. 2021 Jul 29;12(1):4607. doi: 10.1038/s41467-021-24789-z. Nat Commun. 2021. PMID: 34326325 Free PMC article.

9

Fractional proliferation: a method to deconvolve cell population dynamics from single-cell data.

Tyson DR, Garbett SP, Frick PL, Quaranta V. Tyson DR, et al. Among authors: quaranta v. Nat Methods. 2012 Sep;9(9):923-8. doi: 10.1038/nmeth.2138. Epub 2012 Aug 12. Nat Methods. 2012. PMID: 22886092 Free PMC article.

10

An unbiased metric of antiproliferative drug effect in vitro.

Harris LA, Frick PL, Garbett SP, Hardeman KN, Paudel BB, Lopez CF, Quaranta V, Tyson DR. Harris LA, et al. Among authors: quaranta v. Nat Methods. 2016 Jun;13(6):497-500. doi: 10.1038/nmeth.3852. Epub 2016 May 2. Nat Methods. 2016. PMID: 27135974 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

320 results

Search Page